This October, health professionals have an opportunity to amplify awareness, reduce stigma, and improve care for individuals living with attention-deficit/hyperactivity disorder (ADHD). The mission of ADHD Awareness Month is to educate and empower by sharing reliable, evidence-based information grounded in peer-reviewed research.
ADHD is not limited to childhood. It continues through adolescence and into adulthood, affecting approximately 5% of children and 2% to 4% of adults worldwide. Yet, the complexity of ADHD often goes unrecognized, especially when comorbid conditions obscure diagnosis and complicate treatment. These challenges highlight the essential role clinicians play in accurate identification and individualized care planning.
Each patient’s experience with ADHD is unique. Symptom expression can vary throughout the day and across life stages, requiring thoughtful and ongoing management. Effective treatment involves selecting the right medication and therapeutic strategies based on clinical evidence, side-effect profiles, and the presence of co-occurring conditions, all with the goal of achieving consistent, all-day symptom relief.
ADHD Awareness Month serves as a reminder that with continued education and collaboration, we can help more individuals receive the care and understanding they deserve.